how many people are on glp-1 drugs use peaks in middle age, then drops at 65 GLP-1 Receptor Agonist Market Size
Description
E.AshourA
They may be losing weight, but they are also dealing with nausea, constipation, low energy, food aversions, low protein intake, or fear of eating
Interestingly, 24-hour urine total volume did not change significantly
Govindpani K, Turner C, Waldvogel HJ, Faull RLM, Kwakowsky A
How Much Can You Save
Mounjaro (tirzepatide): Patients taking the 15 mg dose lowered their hemoglobin A1C (a way to measure blood sugar over time) by 2.4% in some studies
